On Dec 30, 2020, Beijing Institute of Biological Products Co Ltd’s inactivated COVID-19 vaccines became the first in China to receive conditional approval for marketing.

2020年12月30日,国药集团中国生物北京生物制品研究所新冠灭活疫苗全国首个获批附条件上市,随后2021年2月25日,国药集团中国生物武汉生物制品研究所的新冠灭活疫苗再获附条件上市批件。.jpg

Address: Sinopharm Plaza, No 20 Zhichun Road, Haidian district, Beijing

Postcode: 100191

Tel: 86-10-82287727

Fax: 86-10-62033332

Copyright ©  China National Pharmaceutical Group Co Ltd. All rights reserved. Presented by China Daily. 京公网安备 11040102700104号 京ICP备:14023670号-1
On Dec 30, 2020, Beijing Institute of Biological Products Co Ltd’s inactivated COVID-19 vaccines became the first in China to receive conditional approval for marketing.

2020年12月30日,国药集团中国生物北京生物制品研究所新冠灭活疫苗全国首个获批附条件上市,随后2021年2月25日,国药集团中国生物武汉生物制品研究所的新冠灭活疫苗再获附条件上市批件。.jpg

Address: Sinopharm Plaza, No 20 Zhichun Road, Haidian district, Beijing

Postcode: 100191 Tel: 86-10-82287727

Fax: 86-10-62033332

Copyright ©  China National Pharmaceutical Group Co Ltd.
All rights reserved. Presented by China Daily. 京公网安备 11040102700104号
京ICP备:14023670号-1